Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

NCT02738125 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02738125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02738125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
April 29, 2016
Completion date
December 15, 2023
Enrollment
265 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)